Sort   by:  
 Page size 
UnknownActivating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
Not available
S-EPMC5456373 | biostudies-literature
UnknownAssociation of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.
Not available
S-EPMC7428808 | biostudies-literature
UnknownHigher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions.
Not available
S-EPMC12508813 | biostudies-literature
UnknownOutcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4766028 | biostudies-literature
UnknownBaseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3536921 | biostudies-literature
UnknownOutcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4306628 | biostudies-literature
UnknownRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Not available
S-EPMC3389193 | biostudies-literature
UnknownThiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276 | biostudies-literature
UnknownPredominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893 | biostudies-literature
UnknownProgression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Not available
S-EPMC6246813 | biostudies-literature
Sort   by:  
 Page size